Skip to Content

Orion Oyj Class B ORINF

Morningstar Rating
$47.16 +9.72 (25.96%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ORINF is trading at a 4% premium.
Price
$38.24
Fair Value
$43.94
Uncertainty
Medium
1-Star Price
$29.84
5-Star Price
$86.82
Economic Moat
Qdbcdx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ORINF is a good fit for your portfolio.

Trading Information

Previous Close Price
$37.44
Day Range
$47.1647.16
52-Week Range
$37.0047.16
Bid/Ask
$40.37 / $42.98
Market Cap
$6.62 Bil
Volume/Avg
3,750 / 3,393

Key Statistics

Price/Earnings (Normalized)
26.76
Price/Sales
4.34
Dividend Yield (Trailing)
4.55%
Dividend Yield (Forward)
4.55%
Total Yield
4.86%

Company Profile

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Core
Total Number of Employees
3,632

Comparables

Valuation

Metric
ORINF
OKDAV
BEACONPHAR
Price/Earnings (Normalized)
26.7643.0396.72
Price/Book Value
6.061.1610.01
Price/Sales
4.340.146.73
Price/Cash Flow
26.12
Price/Earnings
ORINF
OKDAV
BEACONPHAR

Financial Strength

Metric
ORINF
OKDAV
BEACONPHAR
Quick Ratio
1.590.550.39
Current Ratio
3.100.801.22
Interest Coverage
56.00−6.571.76
Quick Ratio
ORINF
OKDAV
BEACONPHAR

Profitability

Metric
ORINF
OKDAV
BEACONPHAR
Return on Assets (Normalized)
12.27%−2.68%4.42%
Return on Equity (Normalized)
20.50%−12.50%10.60%
Return on Invested Capital (Normalized)
16.72%−6.80%9.26%
Return on Assets
ORINF
OKDAV
BEACONPHAR
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LLY
Eli Lilly and CoBnn$731.2 Bil
JNJ
Johnson & JohnsonTpw$389.8 Bil
MRK
Merck & Co IncPrr$328.0 Bil
ABBV
AbbVie IncZrn$314.6 Bil
NVS
Novartis AG ADRStydv$212.8 Bil
RHHBY
Roche Holding AG ADRPmsq$212.4 Bil
AZN
AstraZeneca PLC ADRCnzt$200.6 Bil
PFE
Pfizer IncSzd$156.8 Bil
AMGN
Amgen IncNvvd$155.0 Bil
SNY
Sanofi SA ADRFwxcq$121.2 Bil

Sponsor Center